Finally this study used RCS to explore the non-linear relationship between S100A12 and PAD risk and find the cutoff of the change of correlation between the two, which made the results of this study more accurate and can better guide the assessment of PAD risk and subsequent studies. This evidence concerns the gene S100A12 and peripheral arterial disease.